Symbols

HIMS

Hims & Hers Health·NYSE

--(--)

HIMS fundamentals

HIMS Q4 2025 Earnings

Hims & Hers Health (HIMS) released its earnings on Feb 23, 2026: revenue was 617.82M (YoY +28.41%), missed estimates; EPS was 0.08 (YoY -27.27%), beat estimates.

Revenue / YoY

617.82M

+28.41%

EPS / YoY

0.08

-27.27%

Report date

Feb 23, 2026

HIMS Earnings Call Summary for Q4,2025

Revenue Growth: Q4 2025 revenue up 28% YoY to $618M, driven by new specialties and 400% YoY international expansion.
GLP-1 Mitigation: Non-GLP-1 offerings generate >80% of cash flow; 70% of Labs customers identify treatable risks.
International Ambition: $1B+ annual international revenue target by 2030, with Eucalyptus acquisition for $1.15B.
AI & Innovation: Conversational AI boosts engagement, YourBio at-home testing to launch in 2026.
Financial Health: 2025 operating cash flow $300M, $929M cash on hand, 2026 EBITDA guidance $300M-$375M.

Earnings

EPS

Revenue

Revenue & Expenses

HIMS has released its 2025 Q4 earnings report, with revenue of 617.82M, reflecting a YoY change of 28.41%, and net profit of 20.60M, showing a YoY change of -20.84%. The Sankey diagram below clearly presents HIMS's revenue sources and cost distribution.

Key Indicators

Hims & Hers Health (HIMS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Hims & Hers Health (HIMS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Hims & Hers Health (HIMS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Hims & Hers Health (HIMS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown